Inify Laboratories
Magnus Aurell has a strong background in the medical imaging industry, with experience in business development, sales, and marketing. Magnus has held positions in various companies such as Inify Laboratories, ContextVision AB, AMRA Medical AB, and EXINI Diagnostics AB. Magnus has also served as CEO in companies like EXINI Diagnostics AB and SharpView AB. With a Master of Science degree in Biophysics from Uppsala University, Magnus Aurell has a wealth of knowledge and expertise in the field.
This person is not in any offices
Inify Laboratories
Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI- supported workflow to optimize quality and response times, initially within prostate. The concept is scalable and can be extended to other diagnoses. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. The report is assisted by our own AI, proven in clinical studies to have world-leading accuracy. The complete workflow is supported by a tailor-made process control system. The company, based in Sweden, became independent in 2022 through a spin-off from ContextVision, with 40 years of experience within digital imaging for medical applications. It is listed on Euronext Growth Oslo under the ticker INIFY.